Search Results

Filter
  • 1-10 of  304,416 results for ""Cholesterol, LDL""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The clinical impact of estimating low-density lipoprotein cholesterol (LDL-C) using different equations in the general population.

  • Authors : Lam R; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.; Manemann SM

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood ; Triglycerides*/Triglycerides*/Triglycerides*/blood; Humans

  • Source: Lipids in health and disease [Lipids Health Dis] 2024 Jul 04; Vol. 23 (1), pp. 210. Date of Electronic Publication: 2024 Jul 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101147696 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-511X

Record details

×
Academic Journal

Remnant cholesterol, LDL cholesterol, and apoB absolute mass changes explain results of the PROMINENT trial.

  • Authors : Doi T; Department of Clinical Biochemistry, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark; The Copenhagen General Population Study, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood ; Cholesterol*/Cholesterol*/Cholesterol*/blood ; Triglycerides*/Triglycerides*/Triglycerides*/blood

  • Source: Atherosclerosis [Atherosclerosis] 2024 Jun; Vol. 393, pp. 117556. Date of Electronic Publication: 2024 Apr 20.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0242543 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1484

Record details

×
Academic Journal

Hypercholesterolemia and inflammation-Cooperative cardiovascular risk factors.

  • Authors : Gallo A; Lipidology and Cardiovascular Prevention Unit, Department of Nutrition, APHP, Hôpital Pitié-Salpètriêre, Sorbonne Université, INSERM UMR1166, Paris, France.; Le Goff W

Subjects: Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/blood ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/epidemiology ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/immunology

  • Source: European journal of clinical investigation [Eur J Clin Invest] 2025 Jan; Vol. 55 (1), pp. e14326. Date of Electronic Publication: 2024 Oct 06.Publisher: Wiley Country of Publication: England NLM ID: 0245331 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2362

Record details

×
Academic Journal

Clinical Efficacy of Ezetimibe Combined with Rosuvastatin in the Treatment of Patients with Primary Hypercholesterolemia Inadequately Controlled by Statin Therapy.

  • Authors : Wei Z; Department of Cardiology, Jilin Province FAW General Hospital, Changchun, Jilin, China.; Wang F

Subjects: Rosuvastatin Calcium*/Rosuvastatin Calcium*/Rosuvastatin Calcium*/therapeutic use ; Rosuvastatin Calcium*/Rosuvastatin Calcium*/Rosuvastatin Calcium*/administration & dosage ; Hypercholesterolemia*/Hypercholesterolemia*/Hypercholesterolemia*/drug therapy

  • Source: British journal of hospital medicine (London, England : 2005) [Br J Hosp Med (Lond)] 2024 Nov 30; Vol. 85 (11), pp. 1-13. Date of Electronic Publication: 2024 Nov 13.Publisher: MA Healthcare Country of Publication: England NLM ID: 101257109 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study.

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/drug therapy ; Dyslipidemias*/Dyslipidemias*/Dyslipidemias*/blood

  • Source: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Nov 11; Vol. 31 (15), pp. 1792-1803.Publisher: Oxford University Press Country of Publication: England NLM ID: 101564430 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab.

  • Authors : Zimerman A; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston.; Clinical Trials Unit, Hospital Moinhos de Vento, Moinhos de Vento College of Health Sciences, Porto Alegre, Brazil.

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/adverse effects ; Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood

  • Source: NEJM evidence [NEJM Evid] 2025 Jan; Vol. 4 (1), pp. EVIDoa2400112. Date of Electronic Publication: 2024 Dec 24.Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model:

Record details

×
Academic Journal

The quality, uniqueness, and causality of NMR-based prediction models for low-density lipoprotein cholesterol subfractions in human blood plasma.

  • Authors : Ye Y; Department of Food Science, University of Copenhagen, Rolighedsvej 26, DK-1958, Frederiksberg C, Denmark.; Markussen B

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood; Humans ; Male

  • Source: Computers in biology and medicine [Comput Biol Med] 2025 Jan; Vol. 184, pp. 109379. Date of Electronic Publication: 2024 Nov 26.Publisher: Elsevier Country of Publication: United States NLM ID: 1250250 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-world exploration of LDL-cholesterol management in patients with atherosclerotic cardiovascular disease.

  • Authors : Shah NP; Duke University Hospital, Division of Cardiology, Durham, NC; Duke Clinical Research Institute, Durham, NC. Electronic address: .

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/blood ; Atherosclerosis*/Atherosclerosis*/Atherosclerosis*/drug therapy

  • Source: American heart journal [Am Heart J] 2025 Jan; Vol. 279, pp. 50-58. Date of Electronic Publication: 2024 Oct 16.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

×
Academic Journal

Lipid-lowering therapy after acute coronary syndromes: a multinational European survey.

  • Authors : Tsaban G; Department of Cardiology, Soroka University Medical Center.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beersheva, Israel.

Subjects: Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/blood ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/drug therapy ; Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood

  • Source: Coronary artery disease [Coron Artery Dis] 2025 Jan 01; Vol. 36 (1), pp. 51-58. Date of Electronic Publication: 2024 Sep 12.Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9011445 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry.

  • Authors : Navar AM; Department of Medicine, Division of Cardiology, UT Southwestern Medical Center, Dallas, TX, USA. Electronic address: .; Shah NP

Subjects: Cholesterol, LDL*/Cholesterol, LDL*/Cholesterol, LDL*/blood ; Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use ; Registries*

  • Source: American heart journal [Am Heart J] 2025 Jan; Vol. 279, pp. 107-117. Date of Electronic Publication: 2024 Jul 06.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

×
  • 1-10 of  304,416 results for ""Cholesterol, LDL""